VIDEO: People with Parkinson’s freeze for ‘mannequin challenge’
Author: Almaz OhenePublished: 5 January 2017
Prep: Cook: Serves:
Parkinson’s campaigners worldwide are taking up the ‘mannequin challenge’ – the latest social media trend to sweep the web – to show that ‘freezing’ is part of everyday life for many people with the condition
To share the reality of ‘freezing of gait’, major Parkinson’s organisations around the world have filmed their own versions of the popular social media trend, the #MannequinChallenge. Here are three of the most popular – from Parkinson’s UK, the Parkinson Voice Project in the US and Parkinson’s NSW in Australia.
It launched a campaign featuring four videos showing people unable to move in everyday scenarios such as crossing the street, making a cup of tea and answering the front door.
The emotive messaging asks viewers to “Donate. Now. So their challenge can end.”
2. Parkinson Voice Project
Patients at the Parkinson Voice Project’s clinic in Texas, US, showed viewers the interactive and dynamic nature of their regular speech therapy classes, as they pause for a minute for the camera stunt.
3. Parkinson’s NSW
The Australian organisation took a different approach and focused on people with Parkinson’s tremors among those frozen in time.
4. Vlaamse Parkinson Liga
This challenge was an initiative by a group from Ghent, Belgium who are part of the Vlaamse Parkinson Liga (VPL), the Flemish Parkinson’s disease association. They wanted to highlight the fact that although Parkinson’s patients freeze due to stability problems, it’s also difficult to freeze on demand. The organisation’s president is Yves Meersman, who is also the lead chef behind the Parki’s Kookatelier project.
First it was ‘planking’, then came the ice bucket challenge, and now ‘mannequin challenge’ videos are sweeping the web – a viral internet video trend where people remain frozen in action like mannequins while a moving camera films them.
Beating ‘burnout’: nine ways to stay positive when caring for your partner
Caring for your partner can be challenging, but it doesn't have to be a bur
3 days ago
New biotech to drive forward GDNF treatment for Parkinson’s disease
UK charity Parkinson’s UK is creating a new company, Vivifi Biotech, to develop a treatment with potential to stop or reverse Parkinson’s disease. The experimental therapy surgically distributes GDNF, a protein that is naturally produced by the brain to protect cells, directly into the brain. The charity previously funded a clinical trial to investigate whether boosting GDNF levels could regenerate dying brain cells in people with Parkinson’s. Over the next two years, it will invest up to £800,000 to prepare for a second trial. Arthur Roach, head of research at Parkinson’s UK, said: “While our initial trial didn’t meet its critical endpoint, it did reveal robust evidence indicating that GDNF can possibly reverse Parkinson’s. This is why Parkinson’s UK is committed to continuing research into this potential treatment.” Vivifi Biotech, Roach added, will “bring the right people together to plan a new trial that meets the needs of patients, regulatory…
New wearable medical device for Parkinson’s disease to launch this year
The Imperial College London Innovation Fund, UK, has invested £205,000 to support UK-based tech company Charco Neurotech in its development of a non-invasive medical device for people with Parkinson’s disease. CUE1, a circular device that attaches to the sternum with medical adhesives, uses specialised vibration to help alleviate physical symptoms of Parkinson’s disease. Initial user testing among people with the condition found that the device improved movement by an average of 16%, with testers reporting benefits for walking and fine motor tasks. Lucy Jung, CEO and co-founder of Charco Neurotech, said: “We believe that CUE1 has the potential to significantly improve [Parkinson’s disease] symptoms through its unique controlled vibration technology. We are excited to continue our work on the device and we look forward to the outcome of our proposed clinical trials.” Charco Neurotech will use the Imperial College investment to initiate a clinical trial and fund the device’s manufacture for…
New study brings scientists a “vital step” closer to understanding Parkinson’s disease
A new study from scientists at the University of Cambridge, UK, has brought researchers “a vital step” closer to discovering the origins of Parkinson’s disease. The research, published in the scientific journal ‘Nature Communications’, offered insights on the protein alpha-synuclein, which clumps together in the neurons of people with Parkinson’s. The study focused on how the protein functions in those without the condition and revealed that it sticks to the inner side of the plasma membrane of nerve cells, but not the outer membrane – an insight that could help in the search for a cure. Lead study author, Dr Giuliana Fusco, said: “This study could unlock more information about this debilitating neurodegenerative disorder that can leave people unable to walk and talk. If we want to cure Parkinson’s, first we need to understand the function of alpha-synuclein, a protein present in everyone’s brains.”